Coronary Physiology Peri-Transcatheter Left-sided Valvular interventions in Patients with Severe Aortic Stenosis or Mitral Regurgitatio
- Conditions
- coronary artery diseasevalvular heart disease10011082
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 150
1. Age >= 18.
2. a. TAVI Cohort: severe aortic valve stenosis for which TAVI is scheduled
after discussion in the Heart Team.
b. TVMR Cohort: severe functional mitral regurgitation for which TVMR
is scheduled after discussion in the Heart Team.
3. At least intermediate coronary artery disease, defined as 50 - 99% DS in a
vessel >=2.5 mm.
4. Elective procedure.
5. Written informed consent.
1. TAVI cohort: height coronary ostia < 10 mm.
2. Severe chronic kindey disease, defined as estimated glomerular filtration
rate < 30 ml/min.
3. Contra-indication for intravenous adenosine (severe asthma or chronic
obstructive pulmonary disease, known allergy to adenosine or precious reported
bronchospasm in response to adenosine).
4. Degenerated surgical or transcatheter aortic valve bioprosthesis.
5. Vessels that have collaterals to a chronic total occlusion or that are
supplied by an arterial or venous bypass graft will not be interrogated in this
study.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The change in the FFR value before and after transcatheter left-sided valvular<br /><br>intervention (i.e. TAVI or TMVR).</p><br>
- Secondary Outcome Measures
Name Time Method